Ukr.Biochem.J. 2021; Volume 93, Issue 4, Jul-Aug, pp. 103-110

doi: doi:

Identification of cortactin molecular forms in human urine and their possible diagnostic value

M. Starykovych1, S. Souchelnytskyi2, O. Fayura3, O. Abrahamovych3,
M. Abrahamovych3, N. Lukavetskyy4, R. Stoika1, Y. Kit1*

1Department of Regulation of Cell Proliferation and Apoptosis, Institute of Cell Biology, National Academy of Scoences of Ukraine;
2College of Medicine, QU Health, Qatar University, Doha, Qatar;
3Department of Internal Medicine № 1, Danylo Halytsky Lviv National Medical University, Ukraine;
4Lviv State Oncology Regional Treatment and Diagnostic Center, Lviv, Ukraine;

Received: 14 September 2020; Accepted: 07 July 2021

The protein composition of human urine reflects changes in the biochemical and physiological status of an individual and has an essential diagnostic value. Using precipitation/extraction methods we isolated a protein with Mr ~100 kDa in a human urine. MALDI TOF/TOF mass spectrometry identified this protein as human Src protein kinase substrate cortactin (UniProtKB/Swiss-Prot: Q14247). Screening of urine samples using Western blotting with specific anti-human cortactin antibodies revealed   different proteins immunologically related to cortactin in healthy humans and patients with liver cirrhosis and lung cancer diseases.  These data  suggest that the level of cortacins isoform in urine might serve as a potential marker for testing acute and systemic diseases.

Keywords: , , ,


  1. Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics. 2006;6(23):6326-6353. PubMed, PubMedCentral, CrossRef
  2. Selevsek N, Matondo M, Carbayo MS, Aebersold R, Domon B. Systematic quantification of peptides/proteins in urine using selected reaction monitoring. Proteomics. 2011;11(6):1135-1147. PubMed, CrossRef
  3. Gajbhiye A, Dabhi R, Taunk K, Vannuruswamy G, RoyChoudhury S, Adhav R, Seal S, Mane A, Bayatigeri S, Santra MK, Chaudhury K, Rapole S. Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics. Proteomics. 2016;16(17):2403-2418. PubMed, CrossRef
  4. Myronovkij S, Negrych N, Nehrych T, Redowicz MJ, Souchelnytskyi S, Stoika R, Kit Y. Identification of a 48 kDa form of unconventional myosin 1c in blood serum of patients with autoimmune diseases. Biochem Biophys Rep. 2016;5:175-179. PubMed, PubMedCentral, CrossRef
  5. Kit Y, Myronovsky S, Starykovych M, Nehrych T, Negrych N, Shorobura M, Nehrych O, Shalay O, Tolstyak Y, Havryluk A, Kril I, Tkachuk S, Stepanenko L, Stoika R. A Short Form of Unconventional Myosin 1C in a Human Blood Serum: Discovery and Investigation. In “Myosin: Biosynthesis, Classes and Function” Eds.:  David Broadbent / Nova Sci. Publ. Inc. Hauppauge NY. 2018, 159-175 p.
  6. Cosen-Binker LI, Kapus A. Cortactin: the gray eminence of the cytoskeleton. Physiology (Bethesda). 2006;21:352-361. PubMed, CrossRef
  7. Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X, Garcia JGN. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem. 2004;279(23):24692-24700. PubMed, CrossRef
  8. MacGrath SM, Koleske AJ. Cortactin in cell migration and cancer at a glance. J Cell Sci. 2012;125(Pt 7):1621-1626. PubMed, PubMedCentral, CrossRef
  9. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-685. PubMed, CrossRef
  10. Zakharchenko O, Greenwood C, Lewandowska A, Hellman U, Alldridge L, Souchelnytskyi S. Meta-data analysis as a strategy to evaluate individual and common features of proteomic changes in breast cancer. Cancer Genomics Proteomics. 2011;8(1):1-14. PubMed
  11. Merchant ML, Powell DW, Wilkey DW, Cummins TD, Deegens JK, Rood IM, McAfee KJ, Fleischer C, Klein E, Klein JB. Microfiltration isolation of human urinary exosomes for characterization by MS. Proteomics Clin Appl. 2010;4(1):84-96. PubMed, CrossRef
  12. Myronovkij S, Negrych N, Nehrych T, Tkachenko V, Souchelnytskyi S, Stoika R, Kit Y. Identification of SER-PRO-CYS Peptide in Blood Serum of Multiple Sclerosis Patients. Protein Pept Lett. 2016;23(9):808-811. PubMed, CrossRef
  13. Ohoka Y, Takai Y. Isolation and characterization of cortactin isoforms and a novel cortactin-binding protein, CBP90. Genes Cells. 1998;3(9):603-612. PubMed, CrossRef
  14. Starykovych M, Antonyuk V, Nehrych T, Negrych N, Horák D, Souchelnytskyi S, Kit O, Stoika R, Ki Y. Isolation and identification in human blood serum of the proteins possessing the ability to bind with 48 kDa form of unconventional myosin 1c and their possible diagnostic and prognostic value. Biomed Chromatogr. 2021;35(4):e5029. PubMed, CrossRef
  15. Manko N, Starykovych M, Bobak Y, Stoika R, Richter V, Koval O, Lavrik I, Horák D, Souchelnytskyi S, Kit Y. The purification and identification of human blood serum proteins with affinity to the antitumor active RL2 lactaptin using magnetic microparticles. Biomed Chromatogr. 2019;33(11):e4647. PubMed, CrossRef
  16. Daly RJ. Cortactin signalling and dynamic actin networks. Biochem J. 2004;382(Pt 1):13-25. PubMed, PubMedCentral, CrossRef
  17. Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, Tyska MJ, Weaver AM. Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol. 2016;214(2):197-213. PubMed, PubMedCentral, CrossRef
  18. Huebner AR, Somparn P, Benjachat T, Leelahavanichkul A, Avihingsanon Y, Fenton RA, Pisitkun T. Exosomes in urine biomarker discovery. Adv Exp Med Biol. 2015;845:43-58. PubMed, CrossRef
  19. Bruschi M, Santucci L, Ravera S, Candiano G, Bartolucci M, Calzia D, Lavarello C, Inglese E, Ramenghi LA, Petretto A, Ghiggeri GM, Panfoli I. Human urinary exosome proteome unveils its aerobic respiratory ability. J Proteomics. 2016;136:25-34. PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.